 |
9 Diseases |  |
0 Trials |
|
0 Trials |  |
4 News |  |
- SCH 900800 / Merck (MSD)
Trial withdrawal: Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) (clinicaltrials.gov) - Dec 22, 2013
P1, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Withdrawn
- SCH 900800 / Merck (MSD)
Enrollment change: Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) (clinicaltrials.gov) - Dec 22, 2013
P1, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Withdrawn N=12 --> 0
- SCH 900800 / Merck (MSD)
Trial initiation date: Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) (clinicaltrials.gov) - Mar 26, 2012
P1, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
N=12 --> 0 Initiation date: Jun 2012 --> Jan 2013
- SCH 900800 / Merck (MSD)
New P1 trial: Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235) (clinicaltrials.gov) - Dec 26, 2011
P1, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.